Status:
UNKNOWN
The Real Word Study of Albumin-binding Taxol for Lung Cancer Treatment
Lead Sponsor:
The First Affiliated Hospital of Anhui Medical University
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The investigators conduct the real world study to explore the efficacy and safety of Albumin-binding taxol in lung cancer .
Eligibility Criteria
Inclusion
- Male or female patients .
- Confirmed by Histopathology or Cytology of Lung Cancer
- Patients should be voluntary to the trial and provide with signed informed consent
- The researchers believe patients can benefit from the study.
Exclusion
- Patients with a known history of allergic reactions and/or hypersensitivity attributed to Albumin-binding taxol or its accessories
- Pregnant or lactating women
- Patients with Albumin-binding taxol contraindications
- Patients of doctors considered unsuitable for the trial
Key Trial Info
Start Date :
January 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03802409
Start Date
January 20 2019
End Date
June 30 2020
Last Update
January 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China, 230000